Sign Out
Zonisamide (Zoresan) is indicated as: Monotherapy in the treatment of partial seizures, with or without secondary generalization, in adults with newly diagnosed epilepsy.
Adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in adults, adolescents, and children aged 6 years and above.
Continue with Google